Mark R. Hurtt

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Mark R.
Hurtt has been Chief Medical Officer of Alseres Pharmaceuticals, Inc. since October 2005.
Previously, he was Senior Director-Clinical Research of Neurogen Corporation, Director-Drug Development and Director-Clinical Research of Pfizer Global Research and Development and Assistant Professor of Neurology and Pathology at the University of Pittsburgh.
Dr. Hurtt received an MD degree from Jefferson Medical College

Precedenti posizioni note di Mark R. Hurtt

Società	Posizione	Fine
University of Pittsburgh	Corporate Officer/Principal	-
Neurogen Corp. Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.	Direttore Tecnico/Scientifico/R&S	-
Pfizer (St. Louis) Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO.	Direttore Tecnico/Scientifico/R&S	-
ALSERES PHARMACEUTICALS, INC.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Mark R. Hurtt

Formazione di Mark R. Hurtt

Sidney Kimmel Medical College

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private